Navigation Links
Protalix BioTherapeutics Announces Public Offering of Common Stock
Date:10/7/2007

CARMIEL, Israel, Oct. 7 /PRNewswire-FirstCall/ -- Protalix BioTherapeutics, Inc. (Amex: PLX), today announced that it has commenced a proposed underwritten public offering of its common stock pursuant to a preliminary prospectus supplement to its effective shelf registration statement. The company is proposing to sell 3,726,708 shares of its common stock and certain selling securityholders are proposing to sell an aggregate of 1,242,236 shares of common stock. The selling securityholders have also granted a 30-day over-allotment option to the underwriters to purchase a number of shares equal to 15% of the aggregate number of shares sold in the initial offering. As the company is endeavoring to raise gross proceeds of approximately $130 million, it may be required to increase the number of its shares to be sold in the proposed offering if the offering price, as determined through negotiation between the company and its underwriters, is lower than the current trading range of the company's common stock on the American Stock Exchange. Protalix BioTherapeutics will not receive any proceeds from the sale of shares of common stock by the selling securityholders.

UBS Securities LLC is acting as sole book-running manager for this offering. CIBC World Markets Corp. is acting as a co-manager for this offering.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction.

Copies of the preliminary prospectus supplement and accompanying prospectus may be obtai
'/>"/>

SOURCE Protalix BioTherapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... , July 28, 2015  Moerae Matrix ... Phase 1 clinical trial with MMI-0100, a first-in-class ... being developed for pulmonary disorders characterized by inflammation ... United Kingdom , is a double-blind, ... evaluating the safety and tolerability of MMI-0100 when ...
(Date:7/28/2015)... Israel , July 28, 2015 ... medicine company utilizing its proprietary plant-based rhCollagen technology ... Shurtz has been appointed Senior Director of Business ... (Photo: http://photos.prnewswire.com/prnh/20150728/246955 ) , ... in marketing, regulatory and business strategy. Prior to ...
(Date:7/27/2015)... ... July 27, 2015 , ... This is a professional ... a basic overview of the industry including definitions, classifications, applications and industry chain ... trends, competitive landscape analysis, and key regions development status. Development policies and plans ...
(Date:7/27/2015)... , ... July 27, 2015 , ... ... international sales network Monday. The venture will bring the world’s most efficient gas ... provides state-of-the-art equipment and technologies to both the industrial and municipal markets. With ...
Breaking Biology Technology:Moerae Initiates Lipopolysaccharide (LPS) Challenge Study of Inhaled MMI-0100 for Pulmonary Disease Following Encouraging Safety and Tolerability Observed in Single Ascending Dose Phase 1 Study 2CollPlant Names Shomrat Shurtz Senior Director of Business Development 22015 Biophotonics Market Global Research 22015 Biophotonics Market Global Research 3BlueInGreen Brings Water Treatment Technology to Florida 2
... ... ... Agricultural improvements will play a key role in tackling Africa’s crucial problems of hunger ... during the World Economic Forum on Africa. , , , , ,“Local infrastructure that ...
... May 6, 2010 Oramed,Pharmaceuticals Inc. (OTCBB: ORMP), a developer ... Phase 2b non-FDA,clinical trial of its flagship oral insulin capsule, ORMD-0801. ... ... Africa evaluated responses of 29 Type 2 diabetes patients,to ORMD-0801. ...
... ... ... -- ProRepro today announced it has become an Autodesk authorized value-added reseller (VAR). ... California. ProRepro’s qualified staff demonstrates in-depth technical and industry knowledge and a commitment to ...
Cached Biology Technology:DuPont Leader: Agricultural Improvements Key to Meeting Growing Food, Water Needs in Africa 2Oramed Pharmaceuticals Reports Results in Phase 2b Trial of Oral Insulin Administration to Type 2 Diabetes Patients 2Oramed Pharmaceuticals Reports Results in Phase 2b Trial of Oral Insulin Administration to Type 2 Diabetes Patients 3ProRepro Becomes a Value-Added Reseller for Autodesk 2
(Date:7/23/2015)... Research and Markets ( http://www.researchandmarkets.com/research/rzzp3v/global_outlook_of ) ... Outlook of the Biometrics Industry 2015 " ... global biometrics market is likely to witness significant ... to the uptake of multiple technologies available. The ... the growth of biometrics in existing applications as ...
(Date:7/21/2015)... , July 21, 2015  NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile ... wallet, announces that it has filed provisional patent ... Method. This invention highlights next ... authorizes an account, but also the user using ...
(Date:7/20/2015)... , July 20, 2015  Acuity Market ... Report: The Convergence of Commerce and Privacy" forecasts ... mobile biometric apps will be downloaded to smart ... The mobile biometrics market is projected to generate ... revenue during the seven-year forecast period.    ...
Breaking Biology News(10 mins):Global Outlook of the Biometrics Industry 2015 2Global Outlook of the Biometrics Industry 2015 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4Biometrics on Smart Mobile Devices to Redefine Digital Identity with 12.9 Billion Biometric App Downloads between 2014 and 2020 2
... As most American families sit down to Thanksgiving dinner, a ... the largest animals on earth feasts on the smallest of ... mammals are known for their extraordinarily long dive times. Elephant ... a time by lowering their heartbeat and storing large amounts ...
... developing a model to explain the motion of atoms ... obstacle to understanding a key component of magnetic resonance. ... to better control of magnetic resonance imaging (MRI) and ... University in Columbus and three institutions in France--the Centre ...
... associate vice president for technology development at NJIT, has ... Science and Technology to assist faculty researchers with the ... to $50,000. The money, known as Gap grants, ... interesting idea and a commercial product. Sixteen ...
Cached Biology News:UBC researcher reveals humpback whales' dining habits -- and costs 2Dancing atoms now understood 2Dancing atoms now understood 3Dancing atoms now understood 4Moving new technologies from the lab to the marketplace 2Moving new technologies from the lab to the marketplace 3
... Acridinium NHS ester can be ... nucleic acids. The covalently bound ... chemiluminescence in the presence of ... proteins can be used as ...
... instrument designed to hold up to 6 strain ... and easy to use design ensures that cells ... cyclic stretching or compression. This unit allows you ... strain to produce 64 unique strain settings. The ...
... The Genome-pULSe Kit delivers a novel procedure ... (non-enzymatic) labeling of whole genome DNA from ... to provide a quick and highly reproducible ... Genome-pULSe consists of a REPLI-g Mini Kit ...
... may be superior to transfection in some ... with PULSin you can study lethal proteins ... of proteins in cells. Likewise, delivery of ... traditional RNA interference experiments. ,With PULSin ...
Biology Products: